Lacosamide Injection
Product Images NDC 70710-1886

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70710-1886). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (13c65ee8 2d1a 4e7e 8489 161691a98977 01)

Chemical structure of lacosamide, showing its molecular arrangement with labeled functional groups including an acetyl group, amide, and a benzyl moiety.*

FDA Label Image

Image (13c65ee8 2d1a 4e7e 8489 161691a98977 02)

A bar graph showing seizure reduction percentages comparing placebo and lacosamide doses in three studies. The y-axis represents median percentage change from baseline in seizure reduction, ranging from 0% to 45%. Each study compares placebo to two lacosamide doses, showing higher seizure reduction with lacosamide across all studies, with specific percentages noted for each group.*

FDA Label Image

Image (13c65ee8 2d1a 4e7e 8489 161691a98977 03)

A line graph showing responder rate (equal to or greater improvement versus worsening) on the vertical axis and percent of patients on the horizontal axis, comparing placebo and three dosing groups of lacosamide injection (200 mg/day, 400 mg/day, 600 mg/day). The graph illustrates the response distribution among patients, with different line styles representing each group.*

FDA Label Image

Lacosamide Injection (13c65ee8 2d1a 4e7e 8489 161691a98977 04)

Label for Lacosamide Injection, USP 10 mg/mL, 200 mg/20 mL single-dose vial for intravenous use. The label includes storage instructions, manufacturer Zydus Lifesciences Ltd., and distributor Zydus Pharmaceuticals (USA) Inc. It also states the container closure does not contain natural rubber latex.*

FDA Label Image

Lacosamide Injection (13c65ee8 2d1a 4e7e 8489 161691a98977 05)

Packaging label for Lacosamide Injection, USP 10 mg/mL (200 mg/20 mL), an intravenous injection. The label indicates a package containing 10 x 20 mL single-dose vials. It includes directions for intravenous use, storage instructions, and a note to dispense the Medication Guide separately. The labeler is Zydus Pharmaceuticals USA Inc., with product NDC 70710-1886-6. Brand name 'novaplus+' is displayed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.